Published in J Exp Med on January 01, 1994
Successful T cell priming in B cell-deficient mice. J Exp Med (1995) 2.52
Cross-tolerance: a pathway for inducing tolerance to peripheral tissue antigens. J Exp Med (1998) 1.83
Induction of tolerance to factor VIII inhibitors by gene therapy with immunodominant A2 and C2 domains presented by B cells as Ig fusion proteins. Blood (2005) 1.71
B cells "transduced" with TAT-fusion proteins can induce tolerance and protect mice from diabetes and EAE. Clin Immunol (2011) 1.44
A quantitative analysis of antigen-presenting cell function: activated B cells stimulate naive CD4 T cells but are inferior to dendritic cells in providing costimulation. J Exp Med (1994) 1.25
Retroviral gene therapy with an immunoglobulin-antigen fusion construct protects from experimental autoimmune uveitis. J Clin Invest (2000) 1.22
Abortive proliferation of rare T cells induced by direct or indirect antigen presentation by rare B cells in vivo. J Exp Med (1998) 1.21
B cells directly tolerize CD8(+) T cells. J Exp Med (1998) 1.20
Induction of hyporesponsiveness to intact foreign protein via retroviral-mediated gene expression: the IgG scaffold is important for induction and maintenance of immune hyporesponsiveness. Proc Natl Acad Sci U S A (1999) 1.15
Cross-linking of membrane immunoglobulin D, in the absence of T cell help, kills mature B cells in vivo. J Exp Med (1995) 1.07
CD40-activated B cells can be generated in high number and purity in cancer patients: analysis of immunogenicity and homing potential. Clin Exp Immunol (2008) 1.05
Genetically transferred central and peripheral immune tolerance via retroviral-mediated expression of immunogenic epitopes in hematopoietic progenitors or peripheral B lymphocytes. Mol Med (1997) 1.04
B cells induce tolerance by presenting endogenous peptide-IgG on MHC class II molecules via an IFN-gamma-inducible lysosomal thiol reductase-dependent pathway. J Immunol (2008) 0.97
B-Cell Gene Therapy for Tolerance Induction: Host but Not Donor B-Cell Derived IL-10 is Necessary for Tolerance. Front Microbiol (2011) 0.90
Toll-like receptor 4-activated B cells out-compete Toll-like receptor 9-activated B cells to establish peripheral immunological tolerance. Proc Natl Acad Sci U S A (2012) 0.89
Identification and characterization of an alternative cytotoxic T lymphocyte-associated protein 4 binding molecule on B cells. Proc Natl Acad Sci U S A (1996) 0.87
CD40-activated B cells can efficiently prime antigen-specific naïve CD8+ T cells to generate effector but not memory T cells. PLoS One (2012) 0.84
Role of dendritic cells in the immune response induced by mouse mammary tumor virus superantigen. J Virol (1999) 0.83
Multiple vaccinations: friend or foe. Cancer J (2011) 0.83
A long-lasting interferon-gamma response is induced to a single inoculation of antigen-pulsed dendritic cells. Immunology (1998) 0.80
The regulated long-term delivery of therapeutic proteins by using antigen-specific B lymphocytes. Proc Natl Acad Sci U S A (2004) 0.80
Inhibitors - cellular aspects and novel approaches for tolerance. Haemophilia (2014) 0.77
CTLA-4 is a second receptor for the B cell activation antigen B7. J Exp Med (1991) 9.94
Binding of the B cell activation antigen B7 to CD28 costimulates T cell proliferation and interleukin 2 mRNA accumulation. J Exp Med (1991) 8.78
CD28-mediated signalling co-stimulates murine T cells and prevents induction of anergy in T-cell clones. Nature (1992) 7.15
T-cell antigen CD28 mediates adhesion with B cells by interacting with activation antigen B7/BB-1. Proc Natl Acad Sci U S A (1990) 6.19
Antigen presentation by chemically modified splenocytes induces antigen-specific T cell unresponsiveness in vitro and in vivo. J Exp Med (1987) 5.48
Long-term survival of xenogeneic pancreatic islet grafts induced by CTLA4lg. Science (1992) 5.36
A new member of the immunoglobulin superfamily--CTLA-4. Nature (1987) 5.10
CD28 activation pathway regulates the production of multiple T-cell-derived lymphokines/cytokines. Proc Natl Acad Sci U S A (1989) 5.07
Role of the CD28 receptor in T-cell activation. Immunol Today (1990) 4.89
B7, a new member of the Ig superfamily with unique expression on activated and neoplastic B cells. J Immunol (1989) 4.61
Cloning of B7-2: a CTLA-4 counter-receptor that costimulates human T cell proliferation. Science (1993) 4.45
B cells turn off virgin but not memory T cells. Science (1992) 4.12
Small B cells as antigen-presenting cells in the induction of tolerance to soluble protein antigens. J Exp Med (1992) 3.52
Identification of an alternative CTLA-4 ligand costimulatory for T cell activation. Science (1993) 3.49
CD28 delivers a costimulatory signal involved in antigen-specific IL-2 production by human T cells. J Immunol (1991) 3.47
Murine Th1 and Th2 clones proliferate optimally in response to distinct antigen-presenting cell populations. J Immunol (1991) 3.44
Expression of interleukin 2 receptors on activated human B cells. J Exp Med (1984) 3.27
Selective induction of B7/BB-1 on interferon-gamma stimulated monocytes: a potential mechanism for amplification of T cell activation through the CD28 pathway. Cell Immunol (1991) 3.12
B lymphoblast antigen (BB-1) expressed on Epstein-Barr virus-activated B cell blasts, B lymphoblastoid cell lines, and Burkitt's lymphomas. J Immunol (1982) 2.93
Functional expression of the costimulatory molecule, B7/BB1, on murine dendritic cell populations. J Exp Med (1992) 2.79
Induction of alloantigen-specific hyporesponsiveness in human T lymphocytes by blocking interaction of CD28 with its natural ligand B7/BB1. J Exp Med (1993) 2.71
CD28 interaction with B7 costimulates primary allogeneic proliferative responses and cytotoxicity mediated by small, resting T lymphocytes. J Exp Med (1992) 2.70
BLAST-2 [EBVCS], an early cell surface marker of human B cell activation, is superinduced by Epstein Barr virus. J Immunol (1985) 2.66
T helper cell subsets require the expression of distinct costimulatory signals by antigen-presenting cells. Proc Natl Acad Sci U S A (1988) 2.21
Functional expression of B7/BB1 on activated T lymphocytes. J Exp Med (1993) 1.98
B cells as antigen-presenting cells: the requirement for B cell activation. J Immunol (1983) 1.93
Induction of classical transplantation tolerance in the adult. J Exp Med (1989) 1.91
Antigen presentation by splenic B cells: resting B cells are ineffective, whereas activated B cells are effective accessory cells for T cell responses. J Immunol (1985) 1.91
Level of mIa expression on mitogen-stimulated murine B lymphocytes is dependent on position in cell cycle. J Immunol (1983) 1.54
Augmentation of normal and malignant B cell proliferation by monoclonal antibody to the B cell-specific antigen BP50 (CDW40). J Immunol (1987) 1.43
Th1 and Th2 clones differ in their response to a tolerogenic signal. J Immunol (1990) 1.31
Induction and mode of action of suppressor cells generated against human gamma globulin. I. An immunologic unresponsive state devoid of demonstrable suppressor cells. J Exp Med (1978) 1.29
Murine B7 antigen provides a sufficient costimulatory signal for antigen-specific and MHC-restricted T cell activation. J Immunol (1992) 1.16
Clonal expansion of human T lymphocytes initiated by dendritic cells. J Exp Med (1989) 1.12
Tolerance induction of allo-class II H-2 antigen-reactive L3T4+ helper T cells and prolonged survival of the corresponding class II H-2-disparate skin graft. J Immunol (1989) 1.11
Costimulatory requirements of murine Th1 clones. The role of accessory cell-derived signals in responses to anti-CD3 antibody. J Immunol (1990) 1.10
Regulation of antigen-presentation-I. IFN-gamma induces antigen-presenting properties on B cells. J Immunol (1988) 1.10
Anti-immunoglobulin augments the B-cell antigen-presentation function independently of internalization of receptor-antigen complex. Proc Natl Acad Sci U S A (1985) 1.04
Characterization of antigen processing and presentation by resting B lymphocytes. J Immunol (1988) 1.01
Differential activation of Th1 and Th2 CD4+ cells by murine brain microvessel endothelial cells and smooth muscle/pericytes. J Immunol (1993) 0.96
Activation and proliferation signals in mouse B cells. VI. Anti-Ig antibodies induce dose-dependent cell cycle progression in B cells. Immunology (1985) 0.93
Effect of gamma radiation on resting B lymphocytes. II. Functional characterization of the antigen-presentation defect. J Immunol (1988) 0.86
B cell presentation of a tolerogenic signal to Th clones. Cell Immunol (1992) 0.85
Different antigen-presenting cells differ in their capacity to induce lymphokine production and proliferation of an apo-cytochrome c-specific T cell clone. J Immunol (1985) 0.84
Molecular analysis of the dissociation between IL-2 production and proliferation in a response of a T cell clone to the antigen presented by B cells. J Immunol (1988) 0.82
A polyclonal model for B cell tolerance. I. Fc-dependent and Fc-independent induction of nonresponsiveness by pretreatment of normal splenic B cells with anti-Ig. J Immunol (1991) 0.82
Control of lymphokine expression in T helper 2 cells. Proc Natl Acad Sci U S A (1989) 0.81
Expression of membrane activation antigens on murine B lymphocytes stimulated with lipopolysaccharide. Cell Immunol (1988) 0.80
Differential requirement for humoral factors for IL-2R expression of murine T cell subsets, Th1, Th2, and CD8Th clones. Cell Immunol (1993) 0.79
Kinetic differences in unresponsiveness of thymus and bone marrow cells. Science (1971) 4.13
A modification of the hemolytic plaque assay for use with protein antigens. J Immunol (1968) 4.02
Immunoglobulins cytophilic for human lymphocytes, monocytes, and neutrophils. J Clin Invest (1975) 3.39
Immunologic properties of bacterial lipopolysaccharide (LPS): correlation between the mitogenic, adjuvant, and immunogenic activities. J Immunol (1975) 3.18
Cellular sites of immunologic unresponsiveness. Proc Natl Acad Sci U S A (1970) 3.01
Immunological unresponsiveness. Adv Immunol (1973) 2.75
Relationship of the structure of bacterial lipopolysaccharides to its function in mitogenesis and adjuvanticity. Proc Natl Acad Sci U S A (1973) 2.61
Patterns of cytokine gene expression by CD4+ T cells from young and old mice. J Immunol (1993) 2.56
Recent observations and concepts in immunological unresponsiveness and autoimmunity. Clin Exp Immunol (1971) 2.45
Analysis of autoimmunity through experimental models of thyroiditis and allergic encephalomyelitis. Adv Immunol (1980) 2.27
Immunologic properties of bacterial lipopolysaccharide (LPS). II. The unresponsiveness of C3H/HeJ Mouse spleen cells to LPS-induced mitogenesis is dependent on the method used to extract LPS. J Exp Med (1975) 2.22
Termination of tolerance to human gamma globulin in mice by antigen and bacterial lipopolysaccharide (endotoxin). J Exp Med (1973) 2.15
Transfer of experimental autoimmune thyroiditis by serum from thyroidectomized donors. J Exp Med (1969) 2.12
The production of thyroiditis and antibody following injection of unaltered thyroglobulin without adjuvant into rabbits previously stimulated with altered thyroglobulin. J Exp Med (1965) 1.96
The age-associated increase in IFN-gamma synthesis by mouse CD8+ T cells correlates with shifts in the frequencies of cell subsets defined by membrane CD44, CD45RB, 3G11, and MEL-14 expression. J Immunol (1993) 1.88
The production of antisera to human gammaGlobulin subclasses in rabbits using immunological unresponsiveness. J Immunol (1968) 1.82
Studies on the induction of immunologic unresponsiveness. 3. Antigen form and mouse strain variation. J Immunol (1969) 1.81
Differences in the expression profiles of CD45RB, Pgp-1, and 3G11 membrane antigens and in the patterns of lymphokine secretion by splenic CD4+ T cells from young and aged mice. J Immunol (1990) 1.79
Cellular events during induction of immunologic unresponsiveness in adult mice. J Immunol (1971) 1.72
Studies on the induction of immunologic unresponsiveness. II. Kinetics. J Immunol (1967) 1.70
Cellular events in the induction of experimental allergic encephalomyelitis in rats. J Exp Med (1976) 1.69
The cellular and subcellular bases of immunosenescence. Adv Immunol (1989) 1.59
B-lymphocytes activation by the Fc region of IgG. J Exp Med (1977) 1.51
Cyclical production of antibody as a regulatory mechanism in the immune response. Adv Immunol (1975) 1.50
The ability of bacterial lipopolysaccharide to modulate the induction of unresponsiveness to a state of immunity. Cellular parameters. J Exp Med (1973) 1.49
Interstitial immune complex thyroiditis in mice: the role of autoantibody to thyroglobulin. J Exp Med (1974) 1.49
Lymphokines and aging: interleukin-2 production and activity in aged animals. J Immunol (1981) 1.48
Studies on the induction of immunologic unresponsiveness. I. Effects of endotoxin and phytochemagglutinin. J Immunol (1967) 1.47
Effect of immunological unresponsiveness on different cell populations. Transplant Rev (1972) 1.45
Regulation of immune response by components of the complement cascade and their activated fragments. Springer Semin Immunopathol (1983) 1.41
Roles of T and B lymphocytes in the termination of unresponsiveness to autologous thyroglobulin in mice. J Exp Med (1974) 1.38
Nonspecific activation of murine lymphocytes. I. Proliferation and polyclonal activation induced by 2-mercaptoethanol and alpha-thioglycerol. J Exp Med (1977) 1.37
Effect of chronic viral infection on the immune system. I. Comparison of the immune responsiveness of mice chronically infected with LCM virus with that of noninfected mice. J Immunol (1973) 1.36
The development of autoimmune thyroiditis in rabbits following injection of aqueous preparations of heterologous thyroglobulins. J Immunol (1967) 1.35
Induction of interleukin 1 secretion and enhancement of humoral immunity by binding of human C5a to macrophage surface C5a receptors. J Exp Med (1982) 1.35
Immunologic properties of bacterial lipopolysaccharide (LPS). III. Genetic linkage between the in vitro mitogenic and in vivo adjuvant properties of LPS. J Exp Med (1976) 1.34
Cell-mediated immunity in aged mice: an underlying lesion in IL 2 synthesis. J Immunol (1982) 1.33
CD4+ T cell activation and tolerance induction in B cell knockout mice. J Exp Med (1996) 1.32
Th1 and Th2 clones differ in their response to a tolerogenic signal. J Immunol (1990) 1.31
Specific suppression of the immune response by HGG tolerant spleen cells. I. Parameters affecting the level of suppression. J Immunol (1976) 1.30
Induction and mode of action of suppressor cells generated against human gamma globulin. I. An immunologic unresponsive state devoid of demonstrable suppressor cells. J Exp Med (1978) 1.29
Transfer of experimental autoimmune thyroiditis with T cell clones. J Immunol (1987) 1.28
Demonstration of a specific receptor for human C5a anaphylatoxin on murine macrophages. J Exp Med (1982) 1.28
The immune response to human gamma-G-immunoglobulin in rabbits unresponsive to Fc fragment and H chain protein. J Immunol (1967) 1.25
The termination of immunological unresponsiveness to bovine serum albumin in rabbits. I. Quantitative and qualitative response to cross-reacting albumins. J Exp Med (1970) 1.24
In vivo induction of tolerance in murine CD4+ cell subsets. J Exp Med (1993) 1.22
T cell regulation of polyclonal B cell responsiveness. I. Helper effects of T cells. J Immunol (1979) 1.21
Fate of antigen-binding cells in unresponsive and immune mice. J Exp Med (1973) 1.20
Immunologic unresponsiveness after gastric administration of human gamma-globulin: antigen requirements and cellular parameters. J Immunol (1980) 1.20
The effect of antigenic competition on antibody production to heterologous proteins, termination of immunologic unresponsiveness and induction of autoimmunity. J Immunol (1967) 1.17
The requirement for adherent cells in the Fc fragment-induced proliferative response of murine spleen cells. J Exp Med (1979) 1.15
Specific, transient suppression of the immune response by HGG tolerant spleen cells. II. Effector cells and target cells. J Immunol (1976) 1.14
Immunologic responsiveness of the C3H/HeJ mouse: differential ability of butanol-extracted lipopolysaccharide (LPS) to evoke LPS-mediated effects. J Exp Med (1978) 1.13
The behavior of autologous thyroglobulin in the circulation of rabbits immunized with either heterologous or altered homologous thyroglobulin. J Immunol (1967) 1.13
Regulation of Fc fragment-induced murine spleen cell proliferation. J Exp Med (1980) 1.12
Studies on the catabolism of gamma- G subunits and chains. J Immunol (1965) 1.10
Splenic role in the regulation of immune responses. Cell Immunol (1977) 1.09
The induction of peripheral T cell unresponsiveness in adult mice by monomeric human gamma-globulin. J Immunol (1989) 1.09
2,4-Dinitrophenyl receptors on mouse thymus and spleen cells. J Exp Med (1973) 1.07
Th1 cell anergy and blockade in G1a phase of the cell cycle. J Immunol (1993) 1.07
Possible roles of suppressor cells in immunologic tolerance. Transplant Rev (1975) 1.07
Inability of the C3a anaphylatoxin to promote cellular lysis. Nature (1980) 1.07
Anti-bovine serum albumin specificity and binding affinity after termination of tolerance to bovine serum albumin. J Immunol (1965) 1.06
Role of C3 in the regulation of a splenic PFC response in rabbits. J Immunol (1980) 1.05
Polyclonal activation of murine B lymphocytes by Fc fragments. I. The requirement for two signals in the generation of the polyclonal antibody response induced by Fc fragments. J Immunol (1980) 1.04
Passive transfer of experimental allergic encephalomyelitis by myelin basic protein-specific L3T4+ T cell clones possessing several functions. J Immunol (1986) 1.04
Polyclonal B lymphocyte activation during Trypanosoma cruzi infection. J Immunol (1980) 1.03
The in vivo formation and fate of antigen-antibody complexes formed by fragments and polypeptide chains of rabbit gamma-G-antibodies. J Exp Med (1966) 1.03
The antibody response in rabbits to previously tolerated antigens. Ann N Y Acad Sci (1965) 1.03
In vivo behavior of homologous and heterologous thyroglobulin and induction of immunologic unresponsiveness to heterologous thyroglobulin. J Immunol (1967) 1.03
Regulation of the immune response. I. The potentiation of in vivo and in vitro immune responses by Fc fragments. J Exp Med (1980) 1.02
Effect of lipopolysaccharide on immunogenicity and tolerogenicity of HGG in C57BL/6J nude mice: evidence for a possible B cell deficiency. J Immunol (1977) 1.02
Nonspecific activation of murine lymphocytes. IV. Proliferation of a distinct, late maturing lymphocyte subpopulation induced by 2-mercaptoethanol. J Immunol (1978) 1.02
Anaphylatoxin-mediated regulation of the immune response. II. C5a-mediated enhancement of human humoral and T cell-mediated immune responses. J Immunol (1983) 1.02
Separation of various B-cell subpopulations from mouse spleen. I. Depletion of B cells by rosetting with glutaraldehyde-fixed, anti-immunoglobulin-coupled red blood cells. Cell Immunol (1979) 1.01
Identification and characterization of the effector region within human C5a responsible for stimulation of IL-6 synthesis. J Immunol (1992) 1.01
Fc fragment activation of T lymphocytes. I. Fc fragments trigger Lyt 1+23- T lymphocytes to release a helper T cell-replacing activity. J Immunol (1981) 1.01
Nonspecific activation of murine lymphocytes. V. Role of cellular collaboration between T and B lymphocytes in the proliferative and polyclonal response to 2-mercaptoethanol. J Immunol (1979) 1.01
Potentiation of the primary humoral immune response in vitro by C5a anaphylatoxin. J Immunol (1982) 1.01
Induction, maintenance and termination of immunologic unresponsiveness to bovine thyroglobulin in rabbits. J Immunol (1967) 1.01
Maintenance of immunologic unresponsiveness to human gamma-globulin: evidence for irreversible inactivation in B lymphocytes. J Immunol (1980) 1.00
B lymphocyte differentiation in the CBA/N mouse: a delay in maturation rather than a total arrest. J Immunol (1980) 1.00
Anaphylatoxin-mediated regulation of human and murine immune responses. Fed Proc (1984) 1.00
Antibody-producing cells in rabbits injected with soluble BSA. I. Hemolytic plaque assay. J Immunol (1968) 1.00
The regulatory effects of cytokines on the induction of a peripheral immunologic tolerance in mice. J Immunol (1990) 0.99
Passive transfer of experimental autoimmune thyroiditis from donor rabbits injected with soluble thyroglobulin without adjuvant. Int Arch Allergy Appl Immunol (1967) 0.99
Antibody-producing cells in rabbits injected with soluble BSA. II. Kinetica and dose response. J Immunol (1968) 0.98
Carbohydrate chains on IgG2b: a requirement for efficient feedback immunosuppression. J Immunol (1985) 0.98
Anticomplementary activity of lipid A isolated from lipopolysaccharides. Proc Soc Exp Biol Med (1973) 0.98
Bacterial lipopolysaccharide (endotoxin) interferes with the induction of tolerance and primes thymus-derived lymphocytes. J Immunol (1981) 0.97
Perpetuation of autoimmune thyroiditis and production of secondary renal lesions following periodic injections of aqueous preparations of altered thyroglobulin. Clin Exp Immunol (1969) 0.97
A cyclical appearance of antibody-producing cells after a single injection of serum protein antigen. J Exp Med (1973) 0.97
C3d-K, a kallikrein cleavage fragment of iC3b is a potent inhibitor of cellular proliferation. J Immunol (1984) 0.97
Biological activities residing in the Fc region of immunoglobulin. Adv Immunol (1987) 0.96
Relationship between molecular size and intra- and extravascular diribution of protein antigens. J Immunol (1968) 0.96
Modulation of the induction and circumvention of immunological tolerance to human gamma-globulin by interleukin 1. J Immunol (1987) 0.95
Maturational changes in CD4+ cell subsets and lymphokine production in BXSB mice. J Immunol (1994) 0.95